Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Market Cap	6.71B
Revenue (ttm)	3.58B
Net Income (ttm)	415.68M
Shares Out	1.51B
EPS (ttm)	0.27
PE Ratio	16.18
Forward PE	9.17
Dividend	0.05 (1.20%)
Ex-Dividend Date	Jul 8, 2025

Volume	3,177,665
Average Volume	5,322,513
Open	4.480
Previous Close	4.480
Day's Range	4.440 - 4.510
52-Week Range	3.050 - 4.880
Beta	0.16
RSI	65.58
Earnings Date	Nov 13, 2025

About EGX:RMDA

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E), together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt. The company manufactures, markets, sells, and stores pharmaceutical reagents for human and veterinary use, and diagnostic reagents for individuals, laboratories, and hospitals; imports pharmaceutical reagents and raw materials; and produces food supplements for human use. It offers a portfolio of ...

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: RMDA

Financial Performance

In 2024, EGX:RMDA's revenue was 2.77 billion, an increase of 44.03% compared to the previous year's 1.92 billion. Earnings were 363.84 million, an increase of 62.79%.